Diseases, Conditions, Syndromes

Research produces different results from key China COVID-19 study

Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...


SGLT2 inhibitors can slow progression of chronic kidney disease

Worldwide, 850 million people are affected by chronic kidney disease (CKD)—a worrying figure, and one that continues to rise. Treatment options for patients with CKD are multiple and often determined by the etiology of ...

Diseases, Conditions, Syndromes

What do heart patients need to know about COVID-19 now?

In the months since COVID-19 emerged, medical experts have learned a lot about the threat it poses to people with issues such as high blood pressure, diabetes, obesity or cardiovascular disease.

page 1 from 10